In this episode of Frost & Sullivan's Growth Podcast, we delve into the transformative world of cell and gene therapy (CGT), exploring its journey from groundbreaking science to commercial viability. As the industry faces the dual challenge of scaling complex therapies while meeting rising demand, we discuss key strategies enabling this shift, including next-generation platforms, automation, and outcome-based pricing models. We examine the critical role of manufacturing in this landscape and address the unique hurdles of clinical trials, such as patient recruitment and regulatory compliance. Join me as we uncover the vast opportunities within CGT and how businesses can strategically position themselves for success in this rapidly evolving sector. Tune in for insights that will help you navigate the complexities of CGT and prepare for future growth.